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Abstract 
Radiotherapy (RT) aims to deliver a spatially conformal dose of radiation to tumours while 
maximizing the dose sparing to healthy tissues. However, the internal patient anatomy is constantly 
moving due to respiratory, cardiac, gastrointestinal and urinary activity. The long term goal of the RT 
community to “see what we treat, as we treat” and to act on this information instantaneously has 
resulted in rapid technological innovation. Specialized treatment machines, such as robotic or gimbal-
steered linear accelerators (linac) with in-room imaging suites, have been developed specifically for 
real-time treatment adaptation. Additional equipment, such as stereoscopic kilovoltage (kV) imaging, 
ultrasound transducers and electromagnetic transponders, has been developed for intrafraction motion 
monitoring on conventional linacs. Magnetic resonance imaging (MRI) has been integrated with 
cobalt treatment units and more recently with linacs. In addition to hardware innovation, software 
development has played a substantial role in the development of motion monitoring methods based on 
respiratory motion surrogates and planar kV or Megavoltage (MV) imaging that is available on 
standard equipped linacs.   
In this paper, we review and compare the different intrafraction motion monitoring methods proposed 
in the literature and demonstrated in real-time on clinical data as well as their possible future 
developments. We then discuss general considerations on validation and quality assurance for clinical 
implementation. 
Besides photon RT, particle therapy is increasingly used to treat moving targets. However, 
transferring motion monitoring technologies from linacs to particle beam lines presents substantial 
challenges. Lessons learned from the implementation of real-time intrafraction monitoring for photon 
RT will be used as a basis to discuss the implementation of these methods for particle RT. 
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1. Introduction  
Radiation therapy (RT) is a cornerstone of cancer treatment owing to its ability to selectively irradiate 
tumoural tissues while sparing healthy tissues (Jaffray 2012). However, accurate spatial dose delivery 
is challenging due to changes in internal anatomy occurring on different time scales. Patient set-up as 
well as day-to-day changes in anatomy such as weight loss or tumour progression or shrinkage, 
known as interfraction motion, can be monitored using image-guided radiotherapy (IGRT) prior to 
treatment delivery. However, intrafractional changes due to bladder filling, peristalsis or tumour drift 
happen on a shorter time scale of minutes which may require intrafraction monitoring. Even faster 
motion caused by respiration or cardiac activity occurs which affects treatment accuracy and real-time 
monitoring of this motion requires a high temporal frequency. Respiration-induced target motion 
(translation, rotation and deformation) of several centimetres has been observed in liver (Case et al 
2009, Worm et al 2013, Park et al 2012, Xu et al 2014, Bertholet et al 2016), lung (Schmidt et al 
2016, Huang et al 2015, Seppenwoolde et al 2002, Kyriakou and McKenzie 2012) and pancreas 
(Jones et al 2015, Campbell et al 2017a, Ahn et al 2004). Cardiac activity can also have a substantial 
effect on the position of lung tumours, mediastinal lymph nodes (Seppenwoolde et al 2002, Scherman 
Rydhög et al 2017, Schmidt et al 2016, Chen et al 2014) or liver tumours (Kitamura et al 2003, 
Bertholet et al 2016). Erratic motion of the prostate, including rotation, was also reported in several 
studies (Huang et al 2015, Poulsen et al 2008b, Ng et al 2012, Tynan et al 2016, Hunt et al 2016, Chi 
et al 2017, Aubry et al 2004, Ghilezan et al 2005, Kupelian et al 2007, Langen et al 2008).  
Motion of the tumour and the surrounding organs during the delivery of a plan designed on a static 
anatomy may result in tumour underdosage and over-exposure of healthy tissues. In order to mitigate 
the detrimental effect of motion on dose delivery, margins are a widely used passive approach aiming 
at ensuring target coverage despite intrafraction motion either by encompassing the entire path 
covered by the target during pre-treatment imaging using an internal target volume (ITV), or by using 
probabilistic margins in a mid-ventilation approach (van Herk 2004, Stroom and Heijmen 2002). 
However, ITV and mid-ventilation approaches may result in large irradiated volumes leading to high 
dose delivery to the organs at risk (OAR) (Kamerling et al 2016a, Ehrbar et al 2016, Wolthaus et al 
2008) while target coverage is not guaranteed, especially in the presence of tumour drift. Active 
motion mitigation techniques such as tracking or gating (Keall et al 2006) allow for margin reduction 
while ensuring target coverage but this requires real-time motion monitoring to trigger the beam 
on/off signal during gating or the tracking feedback loop. 
Intra-fraction motion monitoring and mitigation are particularly needed for stereotactic body RT 
(SBRT), where an ablative dose is delivered to the tumour in a few fractions and tight margins are 
needed to spare the healthy tissues. Because of the high dose delivered per fraction, delivery times are 
also increased with two main consequences. First, large drifts and changes in breathing patterns are 
more likely to occur within a fraction. Second, set-up and drift-related errors may no longer be 
considered random in margins recipes (van Herk 2004, Herschtal et al 2013, Stroom and Heijmen 
2002) and are likely to have a greater impact on dosimetric errors. SBRT with motion mitigation has 
shown promising clinical outcome for abdominal tumours in the recent years (Su et al 2017b, Henke 
et al 2018) and the high disease control rate observed for SBRT of early stage lung cancer patients 
(Onishi et al 2007) is motivating the introduction of dose escalation and SBRT for locally advanced 
lung cancer patients where targeting accuracy and margin reduction are key due to the large irradiated 
volumes (Bainbridge et al 2017). 
The actually delivered dose, taking motion into account, may be estimated from time-resolved motion 
monitoring data (Poulsen et al 2012b, Kamerling et al 2017, Ravkilde et al 2018) and would arguably 
allow to establish more accurate dose-response models than the planned dose (Siochi et al 2015, 
Meijers et al 2019). 
The interest in the RT community to “see what we treat, as we treat” and adapt treatment instantly has 
led to the development of numerous real-time motion monitoring and mitigation techniques. Fully 
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integrated systems such as robotic linear accelerators (linac) and gimbal steered linacs with imaging 
suites were specifically designed to combine motion monitoring with mitigation by dynamic tumour 
tracking and are now routinely used (Depuydt et al 2014, Hoogeman et al 2009). Magnetic resonance 
(MR) imaging was also integrated with treatment machines with two commercial systems (Mutic and 
Dempsey 2014, Raaymakers et al 2017) where gating is applied on the MRIdian (Tetar et al 2018, 
Green et al 2018) and multi-leaf collimator (MLC) tracking has been proposed on the Unity (Glitzner 
et al 2018). Add-on systems such as electromagnetic transponders, surface imaging and ultrasound 
transducers may be interfaced with conventional linacs for automatic gating of the treatment beam 
(Worm et al 2018, Grimwood et al 2018). In addition, conventional linacs alone may provide 3D 
motion monitoring capability (Keall et al 2018b) and mitigation via MLC tracking (Keall et al 2014b, 
Booth et al 2016, Keall et al 2018a) or couch tracking (Ehrbar et al 2017b) although the latter has not 
been used clinically to date.  
In particle therapy, inline motion and anatomical changes along the beam path may have large 
dosimetric effects that cannot fully be accounted for by the use of margins (Engelsman et al 2013, De 
Ruysscher et al 2015). Particle therapy centres have seen the integration of add-on monitoring 
equipment and on-board imaging similar to that of conventional linac systems. However, efforts to 
translate motion monitoring approaches from photon therapy to particle therapy are still challenged by 
the accuracy requirements of particle therapy and the technical challenges of integrating hardware-
focused systems in a particle therapy treatment room.  
In this review, we present the different real-time motion monitoring methods used clinically in photon 
or particle therapy and their possible future developments in section 2. Motion mitigation, active or 
passive, will not be discussed in depth in this review; instead we refer the reader to the AAPM Task 
group 76 report (Keall et al 2006), the paper by (Dieterich et al 2008) and, for proton therapy, to the 
consensus guidelines of the PTCOG thoracic and lymphoma subcommittee (Chang et al 2017). In 
section 3, we discuss the validation of motion monitoring methods at the development or early 
implementation stage (3.1) and general considerations on quality assurance (QA) in clinical practice. 
In section 4, the translation of the experience from photon therapy to particle therapy will be 
discussed. Finally, section 5 concludes this review with a discussion of the presented method and an 
outlook on the expected evolution of motion monitoring in photon and particle therapy. 
2. Real-time intrafraction motion monitoring methods 
In this review, the term “monitoring” will be used for the measurement (or estimation) of the tumour 
or OAR position as a function of time while the term “tracking” will be used only to refer to the 
action of following the tumour with the treatment beam. The tumour or OAR being monitored may 
not be directly visible but monitored using a surrogate (internal or external). In addition, the position 
of visible tumours and OARs is generally reduced to the centre of mass of the structure. Therefore in 
this review, the term “target” refers to the surrogate position or to the centre of mass position for the 
tumour or OAR being monitored. “Real-time monitoring” refers to the measurement and processing 
(or estimation) of target position using solely information that is available at the time of interrogation 
(e.g. image acquisition) with a time delay no longer than 0.5 s for the monitoring of respiratory 
motion. The time delay may be longer for slow motion such as that of the prostate. “Online 
monitoring” refers to monitoring while the patient is on the treatment table. The International 
Organisation of Standardisation  (ISO) 5725-1 (ISO 1994) defines the accuracy of a measure as a 
combination of the trueness (mean error) and precision (standard deviation, SD, of the error). 
Accuracy is often defined as the mean error in motion monitoring reports. In this review, we use the 
term accuracy as intended by ISO 5725-1 and use mean and SD to report trueness and precision. 
The different motion monitoring methods discussed in this review are listed in table 1. The 
corresponding sections are indicated in parenthesis in the first column.  
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Table 1. Overview of the technologies used for real-time motion monitoring. 
Technology 
(section) 
Internal/ 
external 
Dimensions 
Additional 
ionising 
radiation 
Tissue/ 
Tumour/ 
surrogate 
Additional 
equipment 
to standard 
linac 
Online solution (vendor) if 
applicable 
Infrared (2.1.1) External 
1D 
No 
Patient surface No 
RPM (Varian) respiratory 
gating (Figure 1a)  
6 DoF  Fixation devices Yes IRLED (Brainlab) 
Optical (2.1.2) External  
6 DoF 
surface 
No Patient surface Yes 
Align RT (Vision RT) (Figure 
1b) / Catalyst (C-RAD) 
Spirometry 
(2.1.3) 
External 1D No 
Lung volume 
changes 
Yes ABC (Elekta) (Figure 1c)  
Pressure belt 
(2.1.3) 
External 1D No 
Abdomen 
perimeter 
Yes  
Anzai (Anzai Medical) 
(Figure 1d) Bellows 
Thermistor 
(2.1.3) 
External 1D No 
Airflow 
temperature 
Yes Thermistor (non commercial) 
kV/MV (2.2.2) Internal 
3D 
triangulated 
Yes 
Markers 
(prostate) 
No  MSKCC (non commercial) 
kV/kV (2.2.2) Internal 
3D 
triangulated 
Yes 
Markers (multi-
site), vertebrae, 
Cranium 
Dedicated 
machine 
CyberKnife® (Accuray) 
(Figure 2c top) 
Markers (multi-
site) 
Dedicated 
machine 
Vero (Figure 2c bottom) 
(Brainlab and Mitsubishi, 
discontinued) 
Markers (multi-
site) 
Yes  
RTRT 
(non commercial) 
Lung and liver 
tumours 
Yes  
Stereoscopic markerless 
monitoring (non commercial)  
MV (2.2.3) Internal 
2D Beam’s 
Eye View 
No 
Markers, lung 
tumour 
No No online solution 
3D inferred 
Markers 
(prostate) 
kV (2.2.3) Internal 
3D inferred 
Yes 
Markers (multi-
site), vertebrae, 
bronchi, lung 
tumours 
No 
KIM (non commercial,  
Online only for prostate) and 
sequential stereoscopic (non 
commercial,  
online only for vertebrae) 
6D inferred Markers  KIM, not performed online 
Hybrid (2.3) 
Internal 
with 
correlation 
model 
3D Yes  
Markers (multi-
site), lung 
tumours 
Dedicated 
machine 
CyberKnife® Synchrony 
(Accuray) (Figure 2c top) 
Markers (multi-
site) 
Dedicated 
machine 
Vero (Figure 2c bottom) 
(Brainlab and Mitsubishi, 
discontinued) 
Markers (multi-
site), cranium 
Yes  
ExacTrac (Brainlab) (Figure 
2b) 
Markers (lung) Yes 
RTRT + Anzai (non 
commercial) 
Markers (liver) No COSMIK (non commercial) 
Electromagnetic 
(2.4.1) 
Internal 3D No 
Markers (multi-
site) 
Yes  
Calypso (Varian) and raypilot 
(MicroPos Medical, only 
prostate) (figure 5) 
Ultrasound 
(2.4.2) 
Internal 3D No  
Prostate, 
prostate bed 
Yes  
Clarity autoscan (Elekta) 
(Figure 5d) 
Soft tissues 
Modified 4D ultrasound 
system (non commercial) 
MR (2.5) Internal 
2D cine 
(any 
orientation) 
No  Tissues 
Dedicated 
machine 
Unity (Elekta), MRIdian 
(ViewRay) 
(Figure 2d) 
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2.1. Surface imaging and respiratory monitoring 
Respiratory monitoring can provide a surrogate for target motion in the thorax or abdomen and was 
proposed early on for gating (Kubo and Hill 1996). Audio-visual feedback to the patient may help 
improve breathing reproducibility. Surface imaging can provide direct target monitoring in the case of 
chest wall or breast irradiation. It is also considered to be a very reliable surrogate for intracranial 
targets. These methods are characterized by the ease of use and high temporal frequency without 
imposing additional imaging dose to the patient. However, for respiratory monitoring, they rely on the 
stability of the relationship between a certain respiratory level and the target position. 
2.1.1. Infrared-based monitoring 
Intracranial stereotactic radiosurgery (SRS) requires highly accurate treatment delivery. Infrared (IR)-
based monitoring is a non-invasive alternative to fixed-pin systems where a coordinate frame is 
mechanically fixed to the patient’s skull (Lightstone et al 2005). This has led to the commercialisation 
of a number of 6 degree of freedom (DoF) systems using passive IR reflectors either mounted on the 
couch, a bite block, a thermoplastic mask, or the body of the patient (Willoughby et al 2012, 
Lightstone et al 2005, Bova et al 1997). Stereoscopic in-room cameras are used to monitor the IR 
reflector position, acting as surrogate for the tumour position (Jin et al 2008, Willoughby et al 2012). 
In addition, systems such as the ExacTrac 6D (Brainlab) and Real-time Position Management (RPM) 
(Figure 1a) can be used for respiratory gating of extracranial sites. These positioning systems are 
connected to a 6 DoF couch and are capable of beam interruption and patient repositioning during 
treatment with sub-millimetre accuracy (mean and SD of error) (Willoughby et al 2012).  
 
Figure 1: a) Varian respiratory gating system uses an infrared reflective marker. (Image provided courtesy of Varian) b) 
Align RT/OSMS is an optical surface monitoring device (image courtesy of Vision RT) (Vision RT, London, UK). c) Elekta 
Active Breathing Coordinator (ABC) uses a spirometer to monitor lung volume (Courtesy, Helen McNair). d) The Anzai 
pressure belt (Anzai Medical, Tokyo, Japan) monitors the abdominal circumference. 
RPM geometric accuracy was verified against fiducial marker (FM) trajectories for lung, liver and 
pancreas patients (Li et al 2012) and for lung patients treated in deep-inspiration breath-hold (DIBH) 
with visual feedback (Scherman Rydhög et al 2017). For RPM-guided left-sided breast DIBH 
treatments using multiple reflectors, (Fassi et al 2018) reported a median residual 3D set-up error of 
5.8 mm compared with kilovoltage (kV) images of implanted clips.  
To reduce the internal-external correlation uncertainty, IR-based monitoring is often used in 
conjunction with x-ray monitoring as described in section 2.3. In addition, on True Beam linacs 
(Varian), the respiratory gating system can be used in tandem with the kV on-board imaging system 
(OBI) where kV imaging is used to verify the internal target anatomy at the beginning of the gated 
treatment window determined by the RPM signal. If the internal anatomy has changed, the treatment 
can be interrupted and the patient repositioned based on newly acquired volumetric imaging 
(Vinogradskiy et al 2018). 
2.1.2. Surface monitoring 
Optical surface monitoring uses one or multiple high definition (HD) cameras to map the patient’s 
surface. AlignRT (Vision RT)(Figure 1b) uses three such room-mounted cameras while Catalyst (C-
RAD, Uppsala, Sweden) uses two room-mounted cameras. These systems project structured light 
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patterns on the patient such that 6 DoF motion can be estimated (Willoughby et al 2012). Visible light 
from in-room lighting, the reflectivity and colour of patients’ clothing or skin tone can potentially 
affect the accuracy of surface mapping (Willoughby et al 2012). During treatment, the real-time 
detected patient surface can be compared with a reference surface, often obtained from the simulation 
CT. Typically one or more subsets of the surface can be selected as a region of interest (ROI) and are 
used to report the translation and rotation of the patient in real-time via registration to the reference 
surface. This system can also replace skin tattoos for set-up and allow the use of less invasive fixation 
devices for SRS (Li et al 2011a, Pan et al 2012, Hoisak and Pawlicki 2018). Some integrated systems 
such as Vision RT are able to automatically trigger beam-hold when the current surface does not 
match the reference surface. Re-positioning of the patient can be done in-room with immediate 
feedback from the system to guide the optimal match without the need for x-ray imaging. 
Extracranially, surface guidance for intrafraction monitoring was mainly used for breast DIBH 
treatments (Tang et al 2014, Ma et al 2018). The main advantage of DIBH is the increased distance 
between the target volume and the heart resulting in lower dose to the heart and therefore lower rates 
of early toxicity (Zagar et al 2017). Using 3D surface mapping, (Betgen et al 2013) evaluated the 
reproducibility of voluntary DIBH and found a systematic interfractional translation up to 5 mm.  
2.1.3. Other breathing surrogates 
The airflow in and out of the lungs can be monitored using a spirometer which, in turn, is used to 
estimate the air volume inside the lungs at a given time point. The patient breathes through a 
mouthpiece, less leakage-prone than a mask (Wong et al 1999) and wears a nose clip to ensure that all 
the breathing occurs through the mouth (Hoisak et al 2004). In addition to the monitoring, a scissor 
valve can be added and used to maintain the air volume at a chosen level, therefore enforcing a 
breath-hold. This is known as active breathing control (ABC) and was first described by (Wong et al 
1999). A version by Elekta, under the name active breathing coordinator (ABC) (Figure 1c) uses a 
balloon valve which prevents air-flow when inflated. ABC has been used for liver (Eccles et al 2006), 
left breast (Remouchamps et al 2003) and lung (McNair et al 2009) cancer patients. The main 
limitations for the use of ABC is the need for patient compliance, coaching sessions and good 
communication between the radiographer and the patient. 
A thermistor measuring the air temperature may also be used to determine if the patient is inhaling or 
exhaling (Kubo and Hill 1996). 
Pressure systems detect respiratory motion via the varying pressure in a belt around the abdominal 
section of the patient. The Anzai belt (Anzai Medical, Figure 1d) is part of a respiratory gating system 
(Siemens) where a pressure sensor (30 mm diameter, 9.5 mm thickness) is inserted in the belt and 
outputs a binary 5V signal to the linac depending on the gating window parameters.  
2.2. kV and MV x-ray imaging-based methods  
Image-based methods using kV and/or megavoltage (MV) x-ray imaging were a natural development 
from the concept of IGRT extending the use of in-room imaging from pre-treatment to intratreatment. 
As such, these methods represent a considerable body of work.  
X-ray image-based methods come in different hardware configurations of stereoscopic or monoscopic 
imaging (Figure 2a-c) and can be combined with external monitoring (section 2.3). Common to all 
image-based methods is the need for image processing to retrieve the target position information from 
the planar image or set of images. The latency of x-ray image-based methods includes the image 
acquisition time and the processing time (Fledelius et al 2011).  
2.2.1. Marker implantation and real-time segmentation in kV and MV images 
Most commonly, high contrast implanted FM (Figure 3) act as surrogate for the tumour position due 
to poor soft tissue contrast. FM (Figure 3a) are routinely implanted in the prostate for pre-treatment 
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image guidance but may also be implanted percutaneously in the liver, pancreas and lungs or 
bronchoscopically in the peripheral lung (Shirato et al 2007) and in mediastinal lymph nodes 
(Schmidt et al 2016). Endoscopic implantation is possible into or near the digestive tract (Fukada et al 
2013) while spinal and paraspinal lesion implantations are performed surgically (Shirato et al 2007). 
Endovascular coils have also been used as markers for lung tumours (Prévost et al 2008). Thinner 
markers that can take an irregular shape (Figure 3b) may be preferred to regularly shaped markers to 
limit artefacts in reconstructed volumetric images or the risk of migration or implantation 
complication (Hanazawa et al 2017, Castellanos et al 2018). Liquid FM such as Lipiodol (Guerbet, 
France) (Rose et al 2014) or BioXmark (Figure 3c) allow for a personalized injected volume, reduced 
artefacts in reconstructed volume images and reduced dose perturbation for particle therapy at the cost 
of lower contrast in x-ray projection images.  
 
Figure 2: Systems for internal motion monitoring during RT delivery are shown. a) Elekta (Elekta AB, Stockholm Sweden) 
(top, image courtesy of Elekta) and Varian (Varian Medical Systems, Palo Alto, CA) (bottom, image provided courtesy of 
Varian) standard linacs with a deployed MV imager opposite the treatment head and a perpendicularly mounted kV imaging 
system. b) BrainLab ExacTrac (BrainLab AG, Feldkirchen, Germany) with stereoscopic kV imaging and external breathing 
monitoring (top, here mounted on an Elekta linac) and the RTRT system with four kV imaging systems (bottom, reproduced 
from https://rad.med.hokudai.ac.jp/en/research/treatment/tracking/ with permission) c) The robotic CyberKnife® (Accuray 
Inc, Sunnyvale, CA) system and Vero Gimbal (BrainLab and Mitsubishi Heavy Industries, Japan) incorporate stereoscopic 
kV imaging and external breathing monitoring. d) Unity (top, image courtesy of Elekta) and MRIdian (Viewray Inc, 
Cleveland, OH) (bottom) are the two commercially available MR-guided linacs (see section 2.5). 
For any treatment guidance or adaptation based on intrafraction monitoring, markers must be 
segmented automatically in real-time, which is more difficult in MV images that have inherently 
lower contrast than kV images (Mao et al 2008, Lin et al 2013) and may have markers close to or 
outside the field edge (Hunt et al 2016, Poulsen et al 2014, Fledelius et al 2014). MV scatter onto the 
kV imager may also degrade the kV image quality (Fledelius et al 2014, Luo et al 2008) but can be 
efficiently reduced using triggered read-out to eliminate the accumulated MV scatter before each kV 
image acquisition (Poulsen et al 2015a).  
Cylindrical or spherical markers can be segmented in real-time in kV or MV projections using simple 
parametric templates (Fledelius et al 2014, Mao et al 2008, Tang et al 2007, Marchant et al 2012). 
Arbitrarily shaped markers or marker groups require more complex templates that can be generated 
semi-automatically using breath-hold computed tomography (CT) scans (Regmi et al 2014) or fully 
automatically using pre-treatment CBCT projections (Bertholet et al 2017, Campbell et al 2017b). 
The segmented marker position is typically selected as the one with the highest normalized cross-
correlation coefficient between the 2D template and a pre-defined ROI of the projection. There will 
always be a maximum in the normalized cross-correlation hence causing segmentation error if the 
marker is outside of the ROI. A larger ROI increases the chances that the marker is inside the ROI, 
but the computation time increases linearly with the ROI area and the template area, and a larger ROI 
increases the risk of mistaking the marker for some other structure in the image (Fledelius et al 2014). 
Suitable ROIs result in a typical processing time below 10 ms per marker per image (Fledelius et al 
2014, Mao et al 2008). Low cross-correlation coefficients also allow to detect potentially erroneous 
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segmentation in template-based methods (Fledelius et al 2014, Tang et al 2007, Bertholet et al 2017) 
(table 2).  
 
Figure 3: Examples of FM. a) 3 mm-long gold markers (civco, diameter between 0.8 and 1.2 mm) (top) can be implanted in 
any soft tissue (middle) for image guidance. The similar 5x1 mm CyberMark™ was developed specifically for use with 
CyberKnife® (bottom) (civco Radiotherapy, Coralville, IA). b) Gold anchor (Naslund Medical, Sweden) (diameter of 0.28 or 
0.4 mm) (top) and Visicoils (IBA dosimetry, Barlett, TN) (diameter between 0.35 and 1.1 mm) (middle) take an arbitrary 
shape once implanted (bottom). c) The liquid fiducial BioXmark (Nanovi, A/S, Denmark) before (top) and after endoscopic 
assisted implantation (bottom). 
Template-free methods were also proposed using machine-learning with manually labelled data from 
the first treatment fraction as training dataset (Lin et al 2013) or using a Dynamic Programming (DP)-
based method (Wan et al 2014, 2016). Due to the post-processing nature of the DP-based algorithm, it 
has not been used in real-time to date. However, owing to the fast processing time, a pre-treatment 
imaging data set could be acquired to initiate detection and intra-treatment images could be appended 
to the data set as they are acquired for real-time segmentation.  
Table 2: Properties of the marker segmentation algorithms discussed in section 2.2.1. 
Method Marker shape 
Site (patient 
number) 
Image 
type 
Template 
generation 
Manual input 
needed 
Automatic 
error 
detection 
(Fledelius et 
al 2014) Cylindrical Liver (13) 
CBCT
, kV, 
MV Automatic No  
Yes – 
rejected 
segmentation 
(Mao et al 
2008) 
Spherical, 
Cylindrical Prostate (5) 
kV, 
MV  Automatic No  No1 
(Tang et al 
2007) Cylindrical Liver (2) kV 
Automatic 
(from 
library) 
Yes 
(initialization) 
Yes – 
terminates 
segmentation  
(Marchant et 
al 2012) Cylindrical 
Pancreas (2), 
prostate (1) CBCT 
Gaussian 
kernels 
Yes 
(initialization) No1 
(Regmi et al 
2014) 
Arbitrary (Visicoil), 
Cylindrical  
Pancreas (4), 
Gastrointestinal 
junction (6), 
lungs (1) CBCT 
From 
breath-hold 
CT 
Yes (template 
generation pre-
treatment) No  
(Bertholet et 
al 2017) 
Arbitrary (Visicoil), 
Cylindrical 
Thorax (12), 
Abdomen (28)  CBCT Automatic  No 
Yes – 
rejected 
segmentation 
(Campbell et 
al 2017b) 2 
Cylindrical marker 
group Pancreas (15) CBCT Automatic No No1 
(Lin et al 
2013) Cylindrical Prostate (2) MV No  
Yes (manual 
selection of 
training sample at 
fraction 1) No 
(Wan et al 
2016) 2 
Arbitrary (Visicoil, 
embolization coil), 
Cylindrical (Gold, 
Calypso)  
Abdomen (34). 
Lung (5)  CBCT No  No  No  
1 Methods designed to have a 100% detection rate, 2 Not fully demonstrated in real-time 
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Table 2 summarizes the properties of selected methods. Note that accuracy results are not presented 
here. A fair comparison of segmentation algorithms is particularly difficult given the variety of image 
quality, marker type, treatment site, and ground truth data used for the evaluation. 
FM and their implantation represent an added cost and toxicity risk. Percutaneous implantation was 
linked to a risk similar to conventional percutaneous biopsy in lung, pancreas and liver (Kothary et al 
2009) with pneumothorax as the most common complication. For trans-rectal implantation in the 
prostate, the main risk is urinary tract infection. However, it may be minimized by the use of thin 
markers requiring a small needle (Castellanos et al 2018). The use of markers also implies delays in 
the treatment due to the implantation itself but also often a waiting time between implantation and 
planning CT to let markers stabilize although a delay between implantation and planning CT was 
found to be unnecessary in liver patients (Worm et al 2016). Other limitations include marker 
migration and changes in the tumour position relative to the markers due to tissue deformations. 
Especially in the liver where markers are often implanted outside of the tumour to avoid tumour 
seeding during percutaneous implantation, an increased target-surrogate distance has been linked to a 
reduced targeting accuracy (Seppenwoolde et al 2011). For transbronchial implantation in the lungs, 
(Ueki et al 2014) reported a residual intrafractional variation of the tumour position with respect to 
the markers of 1.5 mm in the SI direction. (Shirato et al 2007) reported on the Hokkaido group 
experience in marker implantation in multiple sites with multiple techniques and reported successful 
implantation in 90 of 100 lesions without any serious complication. They observed that there is a 
learning curve among endoscopists regarding fixation rate for implantation in the bronchial tree and 
that the relationship between the markers and tumour can change significantly after two weeks. To 
avoid the risk, cost, and uncertainty related to the use of FM, markerless monitoring in kV and MV 
images may be used for certain sites (section 2.2. and 2.3). 
2.2.2. Stereoscopic imaging methods 
Real-time x-ray imaging is limited to 2D localization information. Ideally, stereoscopic kV imaging is 
used to determine the target position via triangulation with high accuracy. However, this requires 
additional equipment.  
The CyberKnife® system: 
The CyberKnife® system (Figure 2c top) was developed for frameless cranial SRS radiosurgery in the 
1990s (Adler Jr. et al 1997) and shortly thereafter modified to treat extracranial sites (Murphy et al 
2000). The system consists of two ceiling-mounted kV sources, two opposed floor-mounted flat panel 
detectors (FPD) and automatic image processing software controlling a robotic 6MV-linac in real-
time. The robotic linac can re-align the treatment beam with 6 DoF in a non-isocentric manner, 
therefore being the first dedicated treatment machine combining motion monitoring and tracking. The 
system can monitor the target position with 6 DoF by co-registering two simultaneously acquired 
intra-treatment radiographs to CT-generated digitally reconstructed radiographs (DRR). The first 
clinical applications were for markerless monitoring for cranial SRS (Adler Jr. et al 1997) and for 
cervical spine treatment in one patient (Murphy et al 2000). Cranium and spine are well suited for 
markerless monitoring where the high contrast of the bony anatomy allows for confident registration. 
Intratreatment radiographs can only be acquired every 10 or 20 seconds, which is insufficient to 
resolve breathing motion. For respiratory motion, the x-ray monitoring is combined with continuous 
optical monitoring as described in Section 2.3. Although insufficient to resolve respiratory motion, 
stereoscopic imaging on the CyberKnife® system has been extensively used to monitor prostate 
motion during SBRT (Friedland et al 2009, King et al 2012). 
The RTRT system 
High frequency intra-treatment stereoscopic imaging for monitoring was pioneered in the late 1990s 
by (Shirato et al 1999) who installed an orthogonal x-ray imaging system in the treatment room of a 
conventional linac creating the real-time tracking radiotherapy (RTRT) system (Shirato et al 2000). 
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Note that the RTRT system does not perform tracking in the sense of following the tumour with the 
treatment beam. Instead the position of a FM is monitored in real-time and the treatment beam is 
gated (Shirato et al 1999). The imaging part consists of four x-ray sources in the floor corners 
(superior right and left and inferior right and left), with corresponding ceiling-mounted detectors. The 
linac and the imaging system isocenters coincide and only two x-ray systems with unobstructed views 
are used at a time. The linac and the kV imaging system pulses are synchronized such that the kV 
images are free from MV scatter. Thirty kV image pairs are acquired per second and used to detect a 
spherical or Visicoil (Hanazawa et al 2017) FM using a simple template matching algorithm. Beam 
interlocks are set if the cross-correlation coefficient is too low or if the line of sight of the marker in 
the two imagers are further apart than 1.5 mm. The high monitoring rate of the RTRT system has 
permitted to extensively study tumour motion in various anatomical sites (Shirato et al 2007, 
Seppenwoolde et al 2002, Kitamura et al 2003, 2002, Kinoshita et al 2008, Ahn et al 2004, 
Hashimoto et al 2005). 
(Shiinoki et al 2017) proposed to incorporate an RTRT-like system on a Varian linac: the SyncTraX 
system where only two cameras are used but can be set at three possible positions to ensure un-
obstructed view. (Berbeco et al 2004) also proposed a prototype integrated radiotherapy imaging 
system (IRIS). Although IRIS was not used clinically, the idea of a gantry-mounted stereoscopic 
imaging system was later commercialized as the Vero system. 
The Vero system: 
The Vero system (Figure 2c bottom) was described by (Kamino et al 2006) and consists of an O-ring 
gantry with a small gimbals-supported linac head. Two kV sources and opposite FPDs are mounted in 
the O-ring gantry at 45° with respect to the treatment beam and an EPID panel allows beam’s eye 
view (BEV) imaging. Pan and tilt of the gimbals as well as skew angle of the gantry allow the 
treatment beam to track targets affected by respiratory and cardiac motion. The Vero system is used to 
treat patients with real-time tumour tracking (RTTT) based on a hybrid monitoring method (see 
section 2.3). However, (Dhont et al 2017) used the 20 s stereoscopic imaging session (at 11 Hz) used 
for an external correlation model (ECM) building to investigate short and long-term variations in 
breathing induced motion for 19 lung and 18 liver lesions bearing one Visicoil marker each. 
Substantial intrafractional drift (SI) was observed for both treatment sites with mean±SD values of 
4.1±1.7 mm and 3.0 ±1.2 mm for lung and liver lesions respectively. Note that the Vero system is no 
longer commercially available. 
Markerless stereoscopic monitoring: 
In addition to the XSight Lung application described in section 2.3, the other markerless monitoring 
application that has been clinically used is the work of (Mori et al 2016). They have used this 
approach to treat both lung and liver cancer patients, making this the first application of markerless 
monitoring for liver cancer. They use a stereoscopic imaging system to acquire a series of patient 
images throughout the respiratory cycle. Their markerless tumour monitoring method uses multi-
template matching and machine-learning algorithms, template images and a machine-learning 
dictionary file. Learning is performed for each patient based on the pre-treatment images. Once a 
model has been built and verified, the model is applied to process the images in real-time to determine 
the tumour position. The markerless monitoring system derives the beam pause function of their 
carbon ion treatment beam, enabling gated treatment. 
Combined kV/MV: 
On a conventional linac, MV imaging may complement kV imaging for triangulation of the target 
position. However, due to the low contrast of MV imaging, pre-processing techniques are required. 
(Hunt et al 2016) proposed to combine MV digital tomosynthesis (DTS) with kV imaging during 
volumetric arc therapy (VMAT) for patients with prostate cancer using conventional linacs (Figure 
2a). The method was evaluated in phantom experiments and for three prostate patients treated with 
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VMAT, each having three implanted cylindrical fiducials. MV images were acquired continuously at 
~9.5 Hz and arcs between 2 and 7° were used for MV-DTS while kV images were acquired every 20°. 
MV-DTS reduces the visibility of out-of-plane objects such as bony anatomy, however, a greater arc 
may result in blurring of the fiducials due to prostate motion and therefore hinder marker visibility. 
Single MV images or MV-DTS were paired with the corresponding kV image, FM were segmented 
and their 3D positions were determined by triangulation. In patients, motion monitoring results were 
validated against manual FM selection in single MV images triangulated with the closest kV image 
(ground truth position). Marker detection failures increased with the span of the MV-DTS due to 
MLC leaves obstructions of the markers in the MV images. The total processing time for fiducial 
detection in a 4° MV-DTS was 1.1 s of which 0.6 s was the MV-DTS reconstruction time.  
The authors addressed the marker detection failure in MV images by developing an automatic plan 
optimization strategy ensuring that at least one fiducial was always visible (Zhang et al 2016). 
Exposing one fiducial was feasible without loss of plan quality. The method has now been clinically 
implemented to treat more than 110 prostate patients with gating (Keall et al 2018b). The same group 
recently extended the method to markerless kV/MV lung tumour monitoring by registering kV and 
MV images to CBCT projections acquired at the same gantry angle (Zhang et al 2018).  
2.2.3. Monoscopic imaging methods 
KV monoscopic imaging: 
On a standard linac, the kV imaging system is mounted perpendicularly to the linac head (Figure 2a). 
Algorithms are thus used to infer motion in the unresolved dimension. kV images have better contrast 
than MV images, allowing more reliable detection of the target (FM or tumours) position in real time. 
Furthermore, the kV field-of-view can be selected to cover the target independently of the treatment 
beam shape, and kV images may be acquired prior to treatment onset as a training dataset for model 
building and motion prediction. 
When a point target is projected onto an x-ray imager it is known to be located somewhere on the ray 
line between the projection point and the x-ray source. Real-time monoscopic target localization in 
general uses the projected target position in a sequence of training images from different angles to 
establish a model that allows estimation of the unresolved target position along the ray line (and thus 
the 3D position) in a new image. The model is assumed to be constant over a certain time such that it 
can be established by partial information from training images acquired at different times.  
A very simple model is to neglect the motion taking place in the unresolved direction. The unresolved 
target position in the current image can then be determined by triangulation as the position on the ray 
line of a training image that is closest to the ray line of the current image. The triangulation can 
include several training images, possibly with different weights and can be rejected if the ray line is 
more than a certain threshold distance from the ray line of the current image or other training images. 
This is the idea behind Sequential Stereo (Varian Medical System), which was recently used for 
online real-time 3D spine localization during VMAT SBRT delivery (Hazelaar et al 2018c). 
Sequential Stereo (Van Sörnsen De Koste et al 2015) and similar methods (Regmi et al 2014) can be 
used in the presence of respiratory motion provided that training images at the same breathing phase 
and with ray lines sufficiently close to the current image are available for the triangulation. This 
requirement can be avoided, e.g. by assuming a confined 3D target trajectory defined by the mean 3D 
position in two (Park et al 2012) or more (Becker et al 2010) respiratory phases as estimated by back-
projecting sets of phase-sorted training images. The unresolved position of the current image is then 
estimated as the position closest to the confined 3D target trajectory.  
Another approach is to establish a 3D probability density function (PDF) for the target position from a 
sequence of training images and estimate the unresolved position of the current image as the 
expectation or maximum value of the 1D PDF along the ray line. One possibility is a 3D Gaussian 
PDF determined from the projected target positions by maximum likelihood estimation (Poulsen et al 
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2008a). Another possibility is a Bayesian approach, where the 3D PDF is a product of individual 
contributions from training images that have uniform probability distributions along the ray line and 
exponential decay away from the ray line (Li et al 2011b). The PDF based methods can be used for 
both respiratory motion and non-periodic motion such as prostate motion. 
A drawback of PDF-based methods is that the 3D-PDF must be rebuilt periodically to capture the 
possible changes in the distribution of motion (correlation or covariance of the 3D motion). The 
Kalman filter approach can overcome this drawback by iteratively re-estimating the posteriori 
function without solving all the parameters of the PDF (Kalman 1960, Shieh et al 2017). The Kalman 
filter framework implicitly assumes a Gaussian distributions which is computationally more efficient 
than other probabilistic approaches. 
For respiratory motion, another approach is to exploit interdimensional motion correlation to model 
the unresolved LR and AP target positions as a function of the resolved SI position (Chung et al 
2016). The parameters of the correlation model are fitted to the training images in an iterative way to 
account for the position dependent scaling factor between room coordinates and imager coordinates. 
When the correlation model is established, the full 3D position of the current image is estimated from 
the observed SI position. When an external respiratory signal is available a related approach is to 
establish an ECM of the target position along all three axes as function of the respiratory signal (Cho 
et al 2010) (see section 2.3). 
A direct comparison between the different monoscopic methods is difficult since the performance 
depends on several factors such as the image sequence, motion trajectory, and possible model 
parameters. However, a recent comparison reported that the Gaussian and Bayesian PDF, the Kalman 
filter and the interdimensional motion correlation methods all had sub-millimetre accuracy (mean and 
SD of error) with the Gaussian PDF methods being the most precise (Montanaro et al 2018). One 
important limitation of this work is that segmentation, hence, 2D target information, was assumed to 
be perfect. In the presence of noise and segmentation errors, lower accuracy is expected. 
The mostly widely used method is Kilovoltage Intrafraction Monitoring (KIM) which integrates the 
Gaussian PDF method for 3D motion estimation with template-based marker segmentation and has 
been used both retrospectively (Ng et al 2012) and prospectively (Keall et al 2015) for prostate cancer 
patients. In addition, similar systems were used to retrospectively estimate intrafraction motion of 
liver tumours for VMAT treatments (Poulsen et al 2014) and pancreas tumours in daily CBCT (Jones 
et al 2015). For these clinical applications, the tumour location is implicitly inferred by calculating the 
positions of the implanted gold FM. KIM accuracy has so far been evaluated against post-treatment 
triangulation, reporting sub-millimetre accuracy (mean and SD of error) in both retrospective analysis 
(Ng et al 2012) and prospective motion monitoring with beam gating and couch-shifts (Keall et al 
2016). Recently, the KIM system has been extended for six degrees of freedom (DoF) motion 
monitoring in prostate patients (Nguyen et al 2017b). Measurements with a phantom show that sub-
millimetre and sub-degree accuracy can be achieved for both prostate and lung motion traces (Kim et 
al 2017). In future applications, this can be replaced by direct 6 DoF motion estimation from 2D 
projection data to avoid the intermediary 3D estimation step (Nguyen et al 2017a). To date, more than 
120 prostate patients have been treated with KIM monitoring. 
Markers implanted into or adjacent to the tumour give the treatment team high confidence in the 
treatment targeting. However, as discussed in section 2.2.1, markerless approaches are highly 
desirable to avoid the added cost, risk and geometric uncertainty related to the use of FM. Given the 
high-density contrast in the lungs where the lung tissue density is approximately 20% of the tumour 
and surrounding tissue density, lung cancers are an ideal area to explore with x-ray image guidance.  
Early work by (Berbeco et al 2005a) used fixed angle kV beams for tumour position analysis to 
determine when to gate the radiation beam. More recently a number of groups have developed 
sophisticated methods to determine the lung tumour position from these images (Lewis et al 2010, 
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Zhang et al 2014a, Ren et al 2014, Shieh et al 2017, Hazelaar et al 2018a). Though most of the work 
to date has been with single energy images, the ability to acquire dual energy x-rays can help with 
bone signal subtraction for enhanced soft tissue contrast (Patel et al 2015). Of note a recent study 
demonstrated bronchus monitoring on phantom and retrospective patient images (Hazelaar et al 
2018d). Monitoring of the bronchus is interesting as it is an avoidance structure as well as a surrogate 
for the target position therefore allowing simultaneous tumour and normal tissue monitoring. 
MV monoscopic imaging:  
MV imaging using the treatment beam itself as a source and an electronic portal imaging device 
(EPID) is known as beam’s eye view (BEV) imaging and does not add imaging dose to the patient. In 
addition, although MV BEV monitoring is not 3D, it does yield motion measurements in the two 
dimensions most sensitive to motion for photon radiotherapy, i.e. perpendicular to the treatment beam. 
However, MV imaging has poorer soft tissue and marker contrast than kV imaging, can only be used 
when the treatment beam is on, and the field of view is limited to the treatment beam and affected by 
the amount of beam modulation. BEV MV imaging was proposed both for marker and markerless 
monitoring. 
In pioneering work, (Deutschmann et al 2012) used MV imaging of four markers implanted into the 
prostate to estimate the positional and rotational pose of the prostate and adapt the treatment 
accordingly. The prostate position was determined prior to each IMRT segment, and the segment 
positions for the IMRT treatment were adjusted accordingly without needing to adjust the couch 
position. To achieve this, a record-and-verify system with integrated treatment planning system had to 
be developed. This method was successfully applied in over 1000 fractions for 39 prostate cancer 
patients. The authors found over 2mm prostate drifts in 82% (833) of the fractions. Target rotation of 
>12 degrees was found for 10% of fractions. They concluded that the inter- and intrafraction motion 
measurements and adaptation enabled safe margin reduction. Though 2D motion measurements in 
BEV may be sufficient for photon radiotherapy applications, (Azcona et al 2013) applied a 2D to 3D 
trajectory reconstruction algorithm (Li et al 2011b) to the motion measured in clinical MV prostate 
images to establish the 3D target position during treatment. 
MV BEV motion monitoring was experimentally implemented and demonstrated with MLC tracking 
for SBRT delivery in a pig with an implanted stent (Poulsen et al 2012a). In addition, it was used 
retrospectively for markerless monitoring on clinically acquired lung images (Richter et al 2010, 
Aristophanous et al 2011, Rottmann et al 2013). 
2.2.4. Imaging dose 
As reported in the AAPM TG75 report, a substantial limitation of kV imaging-based motion 
monitoring is the added imaging dose to the patient, especially at the skin surface (Murphy et al 
2007). A kV image from a standard linac delivers 1-3 mGy per image depending on the technique. A 
total added imaging dose of 2-10 mSv was measured for KIM-guided prostate RT at 1Hz and, for 
comparison, the dose typically delivered by one pelvis CBCT scan was 4.3 mSv (Ng et al 2013). On 
the RTRT system (Shirato et al 2004) the skin dose from one fluoroscope was estimated to 29-1182 
mGy/h and was highly dependent on kV peak and pulse duration but less so on skin-isocenter 
distance. Transient or main erythema can appear with an imaging dose of 2000 mGy or 6000 mGy 
respectively (Murphy et al 2007). Skin dose is therefore non-negligible for long IMRT treatments 
with the RTRT system. Depth dose at 5 cm was up to 58% of the peak dose and may also become a 
concern in IMRT treatments. Reduction of field size is an important but insufficient measure to 
reduce the dose, since the same area will receive the same skin dose every day. In a gantry mounted 
system, the source to detector distance is shorter than for the RTRT system which reduces exposure 
by a third compared to that of the RTRT system for a similar dose at the imager. The most direct way 
to reduce exposure remains reducing the imaging frequency as implemented in later generations of the 
RTRT system (Shirato et al 2004) or using hybrid monitoring. 
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2.3. Hybrid methods  
Respiratory monitoring (section 2.1) is a poor surrogate for the position of internal targets (Li et al 
2012, Hoisak et al 2004). To address this shortcoming, intrafraction imaging of FM may be used to 
verify external monitoring (see section 2.1.1). In addition, hybrid monitoring methods were developed 
specifically to combine respiratory monitoring with sparse imaging for internal monitoring. The 
general workflow includes a pre-treatment training phase of simultaneous internal and external 
monitoring where an ECM is built that relates the internal motion to the external motion. During 
treatment, the internal position is estimated from the external signal. Sparse imaging is used to verify 
the stability of the ECM and/or trigger an ECM update or rebuild if needed (see section 2.3.1). Figure 
4 illustrates the kV geometry and gives a schematic overview of the pre-treatment model building and 
intra-treatment monitoring on the various platforms. Note that in all cases, the external monitoring 
(not shown on Figure 4) is provided by ceiling mounted cameras and reflective or emitting markers on 
the patient chest and/or abdomen (section 2.1).  
 
Figure 4: Schematic overview of the geometry, pre-treatment model building and intra-treatment monitoring for the hybrid 
monitoring platforms. Note that the ExacTrac kV imaging system is non-coplanar at 60° angle (Figure 2b) and the MV 
source of the CyberKnife® can move non-isocentrically. 
The CyberKnife® Synchrony system: 
In addition to the robotic linac and kV imaging system of the CyberKnife® system (see section 2.2.2), 
Synchrony comprises a vest fitted with light emitting diodes (LED) markers and three ceiling-
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mounted cameras to monitor external motion at 20-40 Hz (Ozhasoglu et al 2008). Prior to treatment, 
at least eight x-ray pairs are acquired at different breathing phases (including end-inhale and end-
exhale) and used to triangulate the fiducial maker positions (Figure 4a). The external motion is 
continuously recorded, and an ECM is built that relates the internal FM motion to the external marker 
motion (see section 2.3.1). During treatment, the ECM is used to infer the marker positions and re-
align the treatment beam. In addition, new x-ray pairs can be acquired about every 30 seconds to 
directly determine the FM positions by triangulation. The model can be updated on the fly in case of 
small error or completely rebuilt using a new set of eight x-ray pairs after treatment interruption.  
(Hoogeman et al 2009) analysed the log files for the treatment of 44 lung cancer patients on the 
CyberKnife® Synchrony system and calculated the correlation error as the difference between the 
estimated target positions and the actual target position in the intra-treatment images. They found a 
sub-millimetre population mean error (mean of the SDs) in each direction and no difference in 
correlation model error between centrally or peripherally located tumours. 
(Bibault et al 2014) reported on markerless lung tumour monitoring using the Synchrony system for 
51 patients. The method is known as Xsight Lung Tracking System and allows to use the DRR 
method (see section 2.2.2) for lung tumours larger than 15 mm located in the apex and peripheral lung 
region and further than 15 mm away from major vessels and ribs. Another detectability criterion was 
that the projection of the tumour onto the spine must be at an angle different from 45°. 
The ExacTrac system: 
The ExacTrac system (Figure 2b, Figure 4b) combines an IR camera system with two floor-mounted 
kV sources and opposite ceiling-mounted detectors (Willoughby et al 2006a). Between five and seven 
external IR reflective markers are placed on the patient and detected by ceiling-mounted cameras (see 
section 2.1.1). An IR reflective star is placed on the couch and used for automatic couch adjustments. 
During treatment, when the external signal matches the reference gating level, an x-ray image pair is 
acquired and the 3D triangulated position of a FM is compared with its reference position. If there is a 
discrepancy larger than a set tolerance, the beam is switched off and the couch position is adjusted. 
(Willoughby et al 2006a) and (Verellen et al 2006) reported on the initial clinical experience with 11 
and three lung cancer patients respectively. A 6D fusion option was later implemented to allow 6 DoF 
localization from the kV imaging system (Jin et al 2008). 
In cranial SRS, reflective IR markers placed on a thermoplastic mask may be used for intrafraction 
monitoring (see section 2.1.1). However, the masks are slightly elastic and patients may still move 
within the mask. On the ExacTrac system, x-ray pairs can be acquired and 6DoF position correction is 
obtained by 2D/3D image registration with planning DRRs. Radiograph pairs can be acquired for 
verification pre- and post-treatment (Gevaert et al 2012) 
The Vero system:  
The Vero system described in section 2.2.2 includes an ExacTrac IR camera system. At the start of 
treatment, simultaneous stereoscopic kV imaging at 11 Hz and external IR monitoring at 50 Hz are 
performed in a 20-40 second training session to build an ECM (Figure 4c). During treatment, the 
internal target position is determined from the ECM and stereoscopic images are acquired every 2 
seconds. A ROI corresponding to a 3 mm tolerance radius around the predicted FM position is shown 
and the user can decide to terminate the session if the tolerance is systematically exceeded. (Depuydt 
et al 2014) reported on the first ten liver and lung SBRT patients treated on the Vero RTTT system. 
The ECM building took an average of 2.7 min and was valid for an average (range) of 6.9 min (2.7 – 
17.4 min). Significant cranial and posterior drift were observed for the IR and internal SI signal at the 
beginning of treatment suggesting that the drift was due to patient relaxation. Following a similar 
analysis for ten lung cancer patients, (Akimoto et al 2013) recommended frequent model updates to 
avoid large baseline drift-related errors.  
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RTRT with optical Anzai Belt: 
An RTRT system was installed at the Nippon Telegraph and Telephone corporation Hospital in 
Sapporo, Japan. However, this system only had two kV imagers which may have an obstructed view 
at certain gantry angles (Berbeco et al 2005b). The system was therefore supplemented by an external 
optical system (Anzai Medical) using a laser source and detector on an extendable arm placed on the 
treatment couch. (Berbeco et al 2005b) investigated the residual motion for eight lung cancer patients 
treated with respiratory gating. Amplitude-based gating had slightly lower residual motion than phase-
based gating for irregular breathing. Beam-to-beam and day-to-day variations were observed that 
warrant an adjustment of the gating window during the course of treatment, preferably based on 
online internal imaging. 
COSMIK: 
(Bertholet et al 2018) implemented hybrid monitoring on a standard linac using Combined Optical 
and Sparse Monoscopic Imaging with Kilovoltage x-rays (COSMIK, Figure 4d). The method was 
developed as a hybrid alternative to KIM and therefore uses a similar monoscopic imaging technique 
and the RPM (Varian) as external monitoring device. COSMIK uses a pre-treatment CBCT both for 
patient set-up and as a training data set for ECM building. The FMs are automatically segmented in 
the CBCT projections (Bertholet et al 2017) and their 3D trajectories are estimated using the Gaussian 
PDF method (Poulsen et al 2008a). The 3D FM trajectories are used for automatic patient set-up 
(Worm et al 2012) and to fit an augmented linear ECM (Ruan et al 2008). During treatment, the 
internal FM positions are estimated from the continuous external signal using the ECM. kV images 
are acquired every 3 seconds, the FMs are segmented and their 3D positions are estimated. The ECM 
is updated based on the last three images for baseline drift between the internal and external signal. 
COSMIK can be used for non-coplanar fields without imaging, using the latest updated ECM. 
COSMIK was validated in phantom experiments and simulations and used on 14 liver SBRT patients 
treated with implanted FM without motion mitigation. COSMIK was more recently combined with 
real-time 4D dose reconstruction (Skouboe et al 2019, Ravkilde et al 2018). 
2.3.1. Correlation models and update strategies 
Hybrid methods with ECM updates are more accurate than monitoring based on respiratory signals 
alone (Poels et al 2014, Bertholet et al 2018, Malinowski et al 2013) but less accurate than continuous 
kV imaging and they cannot be used to monitor non-correlated internal motion such as seen in the 
prostate. Similar accuracy is achievable on specialized equipment and standard linacs because the 
accuracy is limited by the use of an ECM rather than by the way (stereoscopic or monoscopic kV 
imaging) that the ECM is being established (Cho et al 2010, Bertholet et al 2018). Despite the lower 
accuracy related to the use of an ECM, hybrid monitoring presents certain advantages over continuous 
kV imaging such as reduced imaging dose, shorter latency, continuous monitoring even during beam-
off time, robustness to missing or erroneous marker segmentation and compatibility with non-
coplanar treatment fields. 
External/internal correlation and ECMs are therefore central to the use of hybrid methods. Several 
studies have investigated the correlation between breathing and target motion, the stability of that 
correlation, ECMs of different forms, and update strategies (McClelland et al 2013). The external 
motion is often ambiguously related to the internal motion due to hysteresis where the same external 
position results in different internal positions during inhale and exhale. Linear or quadratic models 
cannot model hysteresis but may be combined with state augmentation using a time delayed sample 
(Ruan et al 2008) or the first temporal derivative of the external position (Depuydt et al 2013).  
On the CyberKnife® system, the hysteresis is addressed by using two quadratic functions without 
state augmentation: one for the inhale phase and one for the exhale phase (Seppenwoolde et al 2007). 
However, if the external motion exceeds the value observed during model building, a linear function 
is used to avoid large errors due to quadratic extrapolation. During the training phase, linear as well as 
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dual quadratic models are fitted in each direction of motion. The model with the smallest DoF-
adjusted error is selected. As a result, the selected model may be linear in some directions of motion 
and quadratic in others. Because several external signals are used, the information from the different 
external markers can also be weighted using the Partial Least Square (PLS) method, thus eliminating 
latent variables that do not contribute to the accuracy of the model (Malinowski et al 2012). 
(Malinowski et al 2013) also investigated the effect of model updates on targeting accuracy using two 
statistical metrics based on the external signal alone which resulted in a similar accuracy as updates 
based on estimation errors but required fewer updates. 
(Poels et al 2014) proposed a method for online model update on the Vero system where newly 
acquired data points are used to replace old training data points at the same breathing phase 
(determined by linear interpolation between exhale peaks). The accuracy improvement was significant 
albeit very small between the clinical and online update strategies, however, the treatment time can be 
reduced by about 5 minutes on average with the online update strategy compared to the clinical 
update which requires treatment interruption to rebuild the model. 
(Poels et al 2015) found similar performances for the CyberKnife® dual quadratic (CKDQ), 
CyberKnife® linear and the Vero ECM on a same dataset from 15 liver and lung patients but due to 
the complexity of the model, the latency of internal tumour motion estimation was 15 ms for the 
CKDQ compared to 2 ms for the Vero model. 
2.3.2. Future developments in hybrid motion monitoring and motion  modelling 
(Schnarr et al 2018) proposed to add a gantry-mounted kV imaging system perpendicular to the 
treatment beam on the tomotherapy system (Accuray Inc.) to allow hybrid motion monitoring using 
external optical monitoring combined with sequential monoscopic imaging.  
Future software developments in hybrid motion monitoring include a 6D internal-external correlation 
(6D-IEC) framework using monoscopic kV-imaging in a similar workflow as COSMIK for 6DoF 
hybrid monitoring (Nguyen et al 2018). 
Going one step further, one may want to monitor the motion of the entire anatomical region including 
nearby OAR which may move differently from the target. Deformable motion models allow to 
estimate the respiratory motion of the local 3D anatomy from limited surrogate data that can be 
acquired during treatment (McClelland et al 2013). The surrogate data is often one or more external 
breathing signals (see section 2.1) and the model is similar to an ECM, but can estimate the full 
deformable motion of the local 3D anatomy. Methods have also been proposed that indirectly model 
the relationship between the internal motion and the surrogate data, enabling the use of real-time 2D 
imaging as surrogate data, such as kV-MV projection images (Vandemeulebroucke et al 2009) or 2D 
cine MR images (Stemkens et al 2016) (see section 2.5). Such models have been very popular in the 
research literature over the last 10-15 years (Meschini et al 2017, Thomas et al 2014, Wolfelschneider 
et al 2017, McClelland et al 2013, Stemkens et al 2016), but to date have seen very limited clinical 
use for two main reasons. Firstly, most methods require good quality 3D images which accurately 
depict the respiratory motion in order to build the motion models. The majority of methods proposed 
in the literature use 4DCT images for this purpose, however, 4DCT images only represent a single 
breath-cycle and so cannot be used to accurately model variability in the breathing motion. 
Furthermore, 4DCT images often contain sorting artefacts due to variable motion during acquisition 
which cause inaccuracies and uncertainties in the motion models. Recently, methods have been 
proposed that build the models from 4DMR datasets representing the 3D motion over several breath-
cycles and including breath-to-breath variability (Stemkens et al 2016). One drawback is that such 
datasets can take a long time to acquire and process (Von Siebenthal et al 2007). Alternatively, 
methods have been proposed that fit the motion models directly to unsorted partial or raw imaging 
data, e.g. cine CT volumes, CT/MR slices (McClelland et al 2017), or CBCT projections (Martin et al 
2014). Although promising, these methods still require further development and validation before 
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they are suitable for clinical use. The second issue that has so far prevented the clinical adoption of 
deformable motion models is the lack of methods to verify and update the motion models during 
treatment. One of the key features of the hybrid methods is the ability to intermittently verify and 
update ECMs against new imaging data during treatment (section 2.3.1). However, this is more 
challenging for deformable motion models, since it is not possible to obtain intermittent 
measurements of the full 3D motion during treatment. Future research will need to focus on 
developing methods that use intrafractional imaging data (e.g. 2D MR) to verify and update the 
models and to be sufficiently confident in the accuracy of the motion estimates. 
2.4. Add-ons to standard equipment 
Conventional linacs can be supplemented with add-on systems for motion monitoring. Respiratory 
and surface monitoring were discussed in section 2.1. SyncTraX and ExacTrac were discussed in 
sections 2.2.2 and 2.3. Here we discuss electromagnetic transponders (section 2.4.1, Figure 5a-b)), 
and ultrasound (section 2.4.2, Figure 5d). Note that motion monitoring using a radioactive implant 
(De Kruijf et al 2013) or emission guided radiotherapy (EGRT) based on positron emission 
tomography (PET) tracer detection (Fan et al 2012) have also been proposed. However, neither 
method is commercially available. 
 
Figure 5: a) An anchored electromagnetic transponder (Calypso, Varian Medical Systems) (top) can be implanted 
transbronchially in the lungs while 17G beacons (top, below the anchored beacon) can be implanted in any soft tissue 
(middle). The system is completed by an in-room antenna and console (bottom). (image provided courtesy of Varian) b) 
Raypilot wired electromagnetic transponders (here shown uncoated, courtesy: Thomas Ravkilde) (top) can be implanted and 
removed from the prostate (middle) and plugged in a special couch (bottom) (Raypilot, Micropos Medical, Sweden). c) The 
Clarity Autoscan probe (Elekta) (top) and console (bottom)(image courtesy of Elekta) 
2.4.1. Electromagnetic transponders/transmitters 
Electromagnetic systems provide continuous real-time 3D localization of implanted transponders or 
transmitters without the use of ionizing radiation. The most commonly used system is Calypso 
(Varian Medical Systems), where the transponders are electromagnetic resonance circuits in sealed 
glass capsules (Balter et al 2005). Typically, three transponders with different resonance frequencies 
(300-500 kHz) are implanted in or near the treatment target. An array of excitation coils in a panel 
above the patient excites one transponder at a time while a second array of receiver coils localizes the 
resonating transponder by triangulation. It gives the 3D position of the transponder centroid relative to 
the panel with a frequency of 10-25 Hz. The position relative to the accelerator isocenter is 
determined by three room-mounted cameras that track infrared markers on the panel. Although the 
antenna panel causes changes in beam depth dose curves and beam attenuation, its dosimetric impact 
on clinical treatment plans was reported to be insignificant (Zou et al 2013). 
Calypso was first used clinically in the prostate (Willoughby et al 2006b), where the ability of 
continuous monitoring without ionizing radiation has allowed systematic investigation of motion 
patterns (Kupelian et al 2007). Studies have revealed trends like strong cranial and anterior prostate 
motion correlation, increased likelihood of small to medium (>3-5 mm) prostate displacements with 
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time (but not of large displacements (>7-10 mm))(Langen et al 2008, Su et al 2011), as well as larger 
respiration induced prostate motion in prone position compared to supine position (Shah et al 2011, 
Butler et al 2013). Other clinical sites include the prostate bed following prostatectomy (Zhu et al 
2013), pancreas (Shinohara et al 2012), and liver (Poulsen et al 2015b, Worm et al 2018, James et al 
2016). In lung tissue, the stability of the smooth transponder is a challenge (Shah et al 2013) and an 
anchored version of the transponder with better attachment in the bronchia by five nitinol legs has 
been developed (Booth et al 2016, Schmitt et al 2017).  
Drawbacks of the Calypso system include the requirement of a dedicated non-conducting couch top, 
lack of flexibility to move the installation between treatment rooms, a limited transponder detection 
volume extending maximum 21 cm below the antenna panel, and MR artifacts caused by the 
transponders (Zhu et al 2009). With a diameter of 1.85 mm (14 gauge implantation needle) the first 
generation of Calypso transponders were considerably larger than typical FM, but a thinner 
transponder for a 17 gauge needle is now available. 
A similar system is RayPilot, which is an implantable wired radiofrequency transmitter that receives 
power through a wire from a couch top plate (Kindblom et al 2009, Vanhanen and Kapanen 2016). 
The couch top plate houses receiving antennas that detect the transmitter position and orientation at 
30Hz. The transmitter is implanted transperineally in the prostate with the wire passing through the 
perineum of the patient, and it is removed after treatment completion. Recent clinical studies found 
that the implantation and explantation procedures were feasible and safe, but the studies also reported 
interfractional transmitter position instabilities and recommended to combine real-time prostate 
motion monitoring by RayPilot with an independent IGRT system for daily prostate localization 
(Braide et al 2018, Vanhanen et al 2018). A newer version of the RayPilot, HypoCath, is catheter-
based to remove the need for surgical intervention and allows to localize the urethra as well as the 
prostate.  
2.4.2. Ultrasound methods  
Ultrasound (US) systems are capable of continuous image acquisition in real-time with good soft 
tissue contrast, while not exposing the patient to additional ionising radiation. This enables direct 
monitoring of internal tissue motion and deformation at high spatial and temporal resolutions. Clarity 
AutoscanTM (Elekta) (Figure 5d) is currently the only commercial US system designed for 
intrafraction motion monitoring. Approved specifically for prostate and prostate bed radiotherapy, the 
system incorporates a 3D transperineal US (TPUS) probe and is compatible with standard C-arm 
linacs. As such, Autoscan provides a flexible, cost-effective monitoring system that is unaffected by 
metal hip prostheses and does not require implanted FM. Integration with Elekta linacs enables 
motion mitigation via automated couch correction or gating, typically at an action threshold of 3 mm 
for 5 s, which can be varied if desired. 
The US probe comprises a mechanically swept curvilinear transducer array with a 5 MHz centre 
frequency, which is secured to a baseplate to hold it in place during treatment. Sweeping the 
transducer array produces a continuously scanned 3D field of view. During monitoring, template 
matching based upon normalized cross correlation is used to automatically estimate the motion of a 
target reference volume within the imaging field of view (Lachaine and Falco 2013). The reference 
volume position is encoded in room coordinates by optically monitoring IR markers on the Autoscan 
probe using a room mounted stereoscopic camera (Polaris Spectra, NDI, Canada). Monitoring rates of 
~0.5 Hz are employed for prostate motion monitoring.  
Autoscan’s accuracy was validated in vivo against manual localization of intraprostatic markers in 
EPID images (Grimwood et al 2018, Han et al 2018) and against Raypilot monitoring (Delcoudert et 
al 2017). Characterisations of prostate motion during treatment describe a gradual drift from the 
isocentre with substantial inter-patients variations showing maximum recorded shifts >10 mm and a 
mean SI drift of 0.075 mm/min (Ballhausen et al 2015, Li et al 2017). 
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As a soft tissue imaging modality, US is able to monitor a range of anatomical surrogates where the 
lesion cannot be discerned. This has motivated the use of experimental ultrasound systems to study a 
range of treatment sites beyond the prostate. The upper abdomen is of particular interest, because it is 
susceptible to respiratory motion and is largely accessible to US without obstruction from bony 
anatomy. 
Liver motion monitoring using an adapted Vivid 7 Dimension probe (GE Healthcare, USA) was 
evaluated against Calypso in a free-breathing patient immediately after liver SBRT (Ipsen et al 2017). 
Another group has pioneered the use of an experimental version of Clarity to monitor the 3D position 
of the liver in 13 patients during RT delivered in breath hold (Sihono et al 2017, Boda-Heggemann et 
al 2016, Vogel et al 2018). A 3D US probe was held using a mechanical arm against the rib-cage 
throughout planning CT, CBCT and RT delivery, without interfering with treatment delivery (Boda-
Heggemann et al 2016). The residual intra-breath-hold motion (e.g. drift) measured using US during 
CBCT acquisition was found to correlate well with residual motion measured from CBCT projection 
images (Vogel et al 2018). 
US was also used for motion monitoring of the pancreatic head and surrogate structures, including the 
superior mesenteric artery and portal vein (Omari et al 2016) as well as for diaphragm position 
monitoring as a surrogate for lung tumour position (Mostafaei et al 2018). 
US has been combined with MLC tracking in vitro (Fast et al 2016, Ipsen et al 2016) with a total 
system latency of ~1 s, therefore demonstrating adequate compensation for the slow motion typically 
observed in prostate cancer (Fast et al 2016, Colvill et al 2014). A predictive compensation method 
was demonstrated on sinusoidal target movements, reducing system latencies to 172 ms (Ipsen et al 
2016). This technique illustrates a potential approach to compensate for monitoring latency of 
breathing motion in lung radiotherapy patients, but requires further in vivo evaluation. 
Despite the scarcity of clinical free breathing patient studies, promising findings have also arisen from 
the MICCAI Challenge on Ultrasound Liver Tracking (CLUST), which comprises an open dataset of 
labelled anatomical features in 64 2D and 22 4D in vivo image sequences (De Luca et al 2018). Using 
results from CLUST, an estimation of the impact from monitoring on treatment margins was made, 
indicating a possible 75% reduction. 
Optimal imaging requires careful probe placement to maximise patient-probe contact and to ensure 
adequate anatomical coverage in the field of view. (Fargier-Voiron et al 2016, Li et al 2017) have 
identified a need to control for anatomical deformation and changes to image quality associated with 
variations in probe pressure. Furthermore, at patient set up, the probe must be manually adjusted to 
ensure both reproducible positioning and adequate target volume coverage. Approaches to assist with 
probe-positioning are being investigated (Camps et al 2017, 2018). Remote probe support and robotic 
systems are also being developed to optimise probe placement during both patient set up and 
treatment delivery (Schlosser et al 2012, Su et al 2017a, Sen et al 2017). The implications of placing 
an ultrasound probe within the gantry arc require further consideration of the resulting beam 
attenuation. Monte Carlo probe models have been developed for incorporation with planning software 
(Bazalova-Carter et al 2015) and the integration of robotic ultrasound with the CyberKnife® system 
has also been examined (Gerlach et al 2017). Another mitigation strategy has been pursued whereby a 
probe was manufactured using radiolucent materials to reduce interference with the treatment beam 
(Schlosser and Hristov 2016). Finally, an autonomous system for avoiding the treatment beam 
altogether has also been demonstrated (Schlosser et al 2016). 
2.5. Magnetic Resonance imaging 
Recently, radiotherapy machines with integrated MR imaging have entered clinical practice (Paganelli 
et al 2018). There are currently two commercially available MR-guided treatment systems: the 
ViewRay MRIdian and the Elekta Unity system (Figure 2d) (Lagendijk et al 2014, Mutic and 
Dempsey 2014, Mutic et al 2016, Raaymakers et al 2009). Additionally, two research groups operate 
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prototype systems (Keall et al 2014a, Liney et al 2016, Fallone 2014). The prospect of monitoring 
intrafractional anatomical changes and guiding real-time adaptive radiotherapy with MR imaging was 
one of the driving forces behind the development of these machines. MR imaging offers excellent 
soft-tissue contrast and does not require FM implantation or expose the patient to additional imaging 
dose. However, cancer patients with metal implants (e.g. prostetics, pacemakers) or very large 
patients cannot be examined using MR imaging. 
It is not yet possible to acquire, reconstruct and postprocess 3D MR images at an adequate resolution 
and imaging rate to monitor fast motion. Instead, 2D cine MR imaging, which is able to survey one or 
multiple 2D imaging planes in real-time, may be harnessed to monitor fast-moving tumors and OAR. 
Pioneered in cardiac imaging, cine MR imaging is usually based on gradient-echo MR sequences 
deploying a single radiofrequency pulse (Bernstein et al 2004). This sequence design permits the use 
of very short echo times and, consequently, shorter repetition times, resulting in sub-second 
acquisitions. Varying these settings as well as adding additional sequence components, such as 
preparation pulses, allows measurement of different image contrasts (Figure 6). In addition to 
different contrasts, the image resolution, position and orientation may be adjusted. It is also possible 
to successively survey multiple imaging planes in order to acquire some volumetric information. All 
these imaging parameters influence the maximum imaging rate, typically in the order of a few images 
per second. Additionally, scanner specifications, such as strength of the main and gradient magnetic 
field and read-out electronics, impact the achievable contrast and acquisition speed. 
 
Figure 6: Two coronal 2D cine MR images of a lung cancer patient acquired with different gradient-echo MR sequences. 
One has been acquired with a balanced steady-state free precession sequence providing a T2/T1-weighted contrast, while 
the other was obtained using a spoiled gradient-echo sequence with a T1-weighted contrast (Menten et al, unpublished). 
Image acquisition can be further accelerated by reducing the amount of acquired k-space data. This 
results in either a lower image resolution or a smaller field-of-view. Should neither be acceptable, 
parallel imaging techniques can be deployed to reconstruct undersampled k-space data using multiple 
independent coils to record the subject’s MR signal (Deshmane et al 2012). As the signal measured by 
each coil depends on its position relative to the patient, this additional spatial information can be used 
during image reconstruction. It should be noted that the parallel imaging capabilities of most MR-
linac’s are still limited. While diagnostic MR scanners with 32 or more individual coil channels are 
commercially available, equivalent hardware is still lacking for MR-guided radiotherapy systems. 
2D cine MR imaging can be used to either determine the tumor position directly or indirectly by 
locating a surrogate structure whose movement is correlated with the target motion. In the future, it 
may also be used to monitor target deformations and rotations as well as track nearby OAR. 
Deformable motion models could also be used to estimate the local 3D anatomical motion from 2D 
cine MR images, as discussed in section 2.3.2 (Stemkens et al 2016) (Tran et al 2018). Multiple 
algorithms have been designed to accurately, reliably and quickly extract the position or outline of a 
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volume-of-interest from 2D cine MR images (Bourque et al 2016, Cerviño et al 2011, Feng et al 
2016, Mazur et al 2015, Paganelli et al 2015, Shi et al 2014, Yip et al 2018, Yun et al 2015) with an 
accuracy approaching inter-observer variability. 
So far, most algorithms rely on a set of training contours from 2D cine MR images of the same 
patient. In a clinical workflow, the training data can be collected as part of pre-treatment imaging and 
reliable manual contours can be created while the patient is being prepared for treatment. Potentially, 
algorithms trained on an independent cohort of patients could be used. Several papers have presented 
promising segmentation tools for 3D biomedical images based on deep learning (Ronneberger et al 
2015). However, this has not been explored yet for 2D cine MR imaging in a radiotherapy context. 
Currently, obtaining a training dataset of sufficient size proves difficult as 2D cine MR images are 
rarely acquired in clinical routine. 
Localization accuracy in a 2D plane does not necessarily translate into usefulness to determine an 
anatomical structure’s position and extent in three dimensions. The volume-of-interest may shift 
perpendicularly to the imaging plane or move out of it entirely. For this reason, multiple studies have 
seeked to optimize the number and orientation of 2D cine MR images for real-time adaptive 
radiotherapy (Bjerre et al 2013, Brix et al 2014, Ipsen et al 2016, Menten et al 2018, Tryggestad et al 
2013). While most of these studies show that 2D cine MR imaging can be used to localize a volume-
of-interest in three dimensions, no consensus strategy on image orientation and imaging parameters 
can be derived from the literature. Both, the ideal imaging strategy and deployed image processing 
may depend on the cancer site monitored as well as the desired intrafractional adaptation strategy. 
MR guidance for intrafractional motion monitoring is still at its beginning. However, few clinics have 
begun to deploy on-board MR imaging to guide intrafractional treatment beam gating on the ViewRay 
MRIdian (Henke et al 2018, Green et al 2018, Tetar et al 2018). Gating with an average system 
latency of 394 ms is based on a single sagittal 2D cine MR image acquired using a balanced steady-
state free precision sequence at four frames per second. At Washington University, St. Louis, MO, 
USA, site of the first MR-guided treatment, approximately one third of patients undergoing MR-
guided radiotherapy are treated with gating (Fischer-Valuck et al 2017) mostly for the treatment of 
thoracic and abdominal tumors. Results from initial clinical trials (Acharya et al 2016, Henke et al 
2018) and further research studies will provide much needed experience about the potential of MR 
imaging for intrafractional motion monitoring. 
3. Validation and quality assurance 
3.1. Validation tools for development and early implementation 
A small number of studies have used animals for motion monitoring end-to-end testing (Shchory et al 
2009, Poulsen et al 2012a). While animal experiments represent a realistic end-to-end test, they are 
difficult to perform and may pose ethical concerns. In addition, ground truth motion is unknown in 
animal subjects and experiments are not reproducible. End-to-end experiments using commercially 
available moving phantoms allow reproducible testing of  the technical components as well as to 
evaluate the accuracy and the latency of intrafraction motion monitoring but they lack the realism of 
human subjects in terms of image quality or complexity of motion.  
(Malinowski et al 2007) proposed a motorized platform which can be used to move a rigid phantom or 
dosimeter with high reproducibility (table 3). Anthropomorphic phantoms which provide a more 
realistic representation of patient anatomy during end-to-end tests were also developed (Cheung and 
Sawant 2015, Nioutsikou et al 2006, Kashani et al 2007, Perrin et al 2017, Remmert et al 2007, 
Serban et al 2008, Steidl et al 2012, Haas et al 2014, Biederer et al 2006) with some representative 
examples summarized in table 3. The representation of ribs is particularly important in thoracic 
particle therapy since the presence (or absence) of a rib on the particle beam path may result in under 
(or over-) shoot of the particle beam’s Bragg peak. Detailed features such as vasculature and airways 
are important for accurate deformable image registration in motion modelling. There is typically a 
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trade-off between realism/anthropomorphism and motion trajectory reproducibility and the use of 
animal tissue requires careful expert manipulation and controlled laboratory conditions (Biederer and 
Heller 2003). Highly realistic phantoms can also be generated using 3D printing technology although 
this has been limited to static versions so far (Hazelaar et al 2018b). 
Table 3: Physical phantoms developed by research group.  
Phantom 
(site) 
Deformable 
/Anthropomorphic 
Motion reproducibility Main features 
WashU (any 
site) 
(Malinowski 
et al 2007) 
No / No • Target accuracy 
(mean±SD) < 1mm  
• 3D axis and independent 1D vertical axis. 
• Motorized platform to carry phantom or 
dosimetry equipment 
LuCa (lung) 
(Perrin et al 
2017) 
 
Yes (interior and 
exterior) / Yes 
(high level of 
detail) 
• Stable end in/exhale 
(<1mm). 
• Tumour position varied 
from day to day for a 
given intermediary 
in/exhale pressure. 
• Inflatable/deformable lungs, skeleton, 
muscles skin, solid heart, solid mobile 
tumour (can hold dosimetric films).  
• Motion actuated by an air pump inflating 
the lungs.  
• MR-compatible with visible deforming 
lung features. 
Lung 
(Cheung 
and Sawant 
2015)  
Yes (interior and 
exterior) / Yes (low 
level of internal 
detail)  
• <2 mm day-to-day 
(ascribed to set-up) 
• < 0.25 mm RMS intra-
day 
• Deformable external shell  
• Latex foam insert for lungs 
• Rigid foam diaphragm actuated by the 
WashU motion stage 
Lung 
(Biederer et 
al 2006, 
Remmert et 
al 2007) 
Yes (interior) / Yes 
(animal heart and 
lungs, nodules, 
airways, no ribs) 
• Maximal diaphragm 
displacement precision 
(SD) 1.90 mm (on CT), 
1.47mm (on MR)  
• Reproducibility of 
intermediary phases 
not quantified 
• Porcine lung and heart explants with 
tracheal tube in saline solution, artificial 
pulmonary nodules 
• Water-filled silicon diaphragm inflated or 
deflated by a water pump outside the MR 
room. 
• MR-compatible 
Lung 
(Serban et al 
2008) 
Yes (interior) / Yes 
(only one lung with 
vasculature/airways 
features) 
• within image 
resolution (0.7 x 0.7 x 
1.25 mm3) 
• Lung (natural latex balloon filled with 
damp sponges) in water, thoracic cavity 
(Lucite), diaphragm (motor-actuated 
piston), tumour (Dermasol ellipsoid), 
vascular and bronchial bifurcation (nylon 
wires and Lucite beads) 
Lung (Steidl 
et al 2012) 
Yes (exterior) / Yes 
(low level of 
internal detail, 
cubic tumour) 
• Target accuracy 
(mean±SD) =0±0.09 
mm (input vs log files) 
 
• Artificial skeleton, rubber skin,  
• Tumour: PMMA cube with 20 slots for 
pinpoint ion chambers and 5 films. 
• Sternum-induced thoracic motion 
• 6D robot-actuated tumour motion 
independent of thoracic motion. 
MAESTRO 
(lung) (Haas 
et al 2014) 
Yes (ribcage only) 
/ Yes (no 
vasculature) 
• Millimetre positioning 
precision 
• Inter-cycle 
reproducibility 
<0.16mm RMS 
• Mechanically actuated ribs, stationary 
lungs, trachea and spine in hermetic skin 
(to be filled with water) 
• Robot-actuated tumour motion 
ELPHA 
(liver) 
(Ehrbar et al 
2019) 
Yes (interior) / Yes 
(liver with 
vasculature) 
• Reproducibility 
<0.32mm RMS (inter- 
and intra-day) 
• Soft silicon liver with vasculature (can 
hold dosimetric devices) 
• Static inferior plate and motor-driven 
superior plate 
• Ultrasound and CT contrast 
Computer simulations are also an important part of validation for two main reasons: first, experiments 
are time-consuming and simulations allow a larger data–set to be obtained providing better statistics 
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in a shorter time. Second, simulations allow comparison of various methods with perfect 
reproducibility as well as exploration of other hardware configurations not necessarily available to the 
user (Cho et al 2012, Bertholet et al 2018, Montanaro et al 2018). Digital phantoms may be 
particularly useful for simulations involving multi-modality imaging (Segars et al 2010, Mishra et al 
2012, Paganelli et al 2017). The XCAT phantom was based on visible male and female anatomical 
datasets from the National Library of Medicine (Segars et al 2010, National Library of Medicine n.d.). 
The heart motion model was derived from high resolution cardiac-gated multi-slice CT angiogram. 
The breathing motion model was derived from respiratory gated-CT of healthy subjects and is 
controlled by chest and diaphragm motion curves. The phantom has allowed other researchers to 
closely reproduce tumour shape and location and motion seen in patients (Mishra et al 2012) and to 
adapt it for MR imaging with detailed imaging parameters (Paganelli et al 2017). While state-of-the-
art digital phantoms can simulate realistic looking motion and images and are a valuable tool for 
validation, it is not known how accurately the simulations represent the real motion that can occur in 
human subjects, and they do not enable the end-to-end testing that can be performed with hardware 
phantoms. 
Motion traces used for simulations and experiments should also be carefully chosen. Site-specific 
motion traces measured in patients should be used in generaly and internal traces should be preferred 
to inferred traces especially for the validation of hybrid monitoring methods relying on internal-
external correlation or monoscopic imaging methods relying on inter-dimensional correlation 
(Montanaro et al 2018).  
Note that marker/tumour segmentation errors or uncertainties cannot be reproduced without patient 
data and have to be assessed independently in retrospective clinical studies. 
3.2. Quality assurance  
An important limiting factor for the implementation of motion monitoring in clinical practice is the 
uncertainty of QA procedures. Especially for combination with real-time adaption (tracking) where a 
treatment plan validated pre-treatment is modified on the fly, standard patient-specific QA procedures 
are no longer sufficient. The critical review by (De Los Santos et al 2013) and references herein 
discuss the QA procedures specific to different motion monitoring and/or real-time adaptation 
equipment. The AAPM TG-135 provides recommendations for QA of robotic radiosurgery (Dieterich 
et al 2011), AAPM TG-154 provides recommendations on in-room US QA (Molloy et al 2011), 
AAPM TG-104 provides recommendations for non-radiographic localization systems such as external 
and electromagnetic methods (Willoughby et al 2012). For methods using linac mounted kV and MV 
imaging, the regular linac commissioning methods described by AAPM TG-104 and AAPM TG-142 
cover geometrical and image quality QA (Fang-Fang and John 2009, Klein et al 2009). To complete 
the QA program for KIM, (Ng et al 2014) proposed additional tests based on the existing QA program 
for the Calypso system (Santanam et al 2009). These tests included verification of the static 
localization accuracy, the dynamic localization accuracy, the treatment interruption accuracy, latency 
measurements and clinical conditions accuracy.  
Important considerations for QA procedures are the latencies and geometric tolerances as well as the 
frequency of the tests. (Ng et al 2014) chose a 1 mm geometric tolerance for the KIM QA program as 
it is well below typical margins and in line with other geometric errors such as isocenters or couch 
calibration. In order to set-up a program that is both efficient and effective, (Sawant et al 2010) used 
the failure mode and effect analysis (FMEA) framework to determine the frequency of QA tests for 
Calypso-guided MLC tracking. The industrial engineering FMEA framework consists of (i) charting a 
process tree identifying each step of the procedure (in this case: motion monitoring and adaptation), 
(ii) identifying the potential failure modes at each step, (iii) identifying the corresponding potential 
causes and their downstream effects and, (iv) quantifying the overall risk of the failure based on the 
probability of occurrence (O), severity of the effect (S) and detectability (D). O, S and D scores (from 
1 to 10) can be multiplied to obtain the overall risk probability number (RPN). RPN scores were 
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obtained from a group of MLC tracking experts and tests for failure modes with a score above 125 
were recommended to be performed monthly while other failure modes were recommended as part of 
commissioning, annual quality assurance and after major hardware/software upgrades. The resulting 
MLC tracking-specific QA program adds ~35 min to monthly QA and ~3.5 hours for comprehensive 
testing. 
For MR-linacs, interactions and interfacing of monitoring and treatment delivery tests have to be 
performed in addition to conventional MR scanner and linac QA tests (Tijssen et al 2019). Hybrid 
tests were therefore designed for aspects that are important to the RT-specific aspect of MR imaging 
or that may be impacted by hardware modifications necessary to the integration of the two modalities. 
In particular requirements for geometric fidelity on a large field of view are stricter for MR-guided 
RT than for diagnostic MRI (Tijssen et al 2019, Ginn et al 2017). All QA tests need to be performed 
with MR-safe and/or compatible equipment. 
4. Translation to particle therapy  
The translation of photon therapy motion monitoring concepts to particle therapy facilities was 
mentioned in numerous publications (Shirato et al 2012, Riboldi et al 2012, Seco and Spadea 2015, 
Kubiak 2016, Knopf et al 2016, Trnková et al 2018). However, only few studies have shown results 
from such translations (Shimizu et al 2014, Umezawa et al 2015, Mori et al 2016). Efforts to translate 
motion monitoring and motion mitigation approaches are challenged by stricter accuracy requirements 
in particle therapy than in photon therapy. Particle dose distributions have a steeper dose fall-off at the 
distal edge of the Bragg peak and are sensitive to inline anatomical changes. Furthermore, in particle 
beam scanning (PBS), the interplay effect challenges the dose homogeneity for moving targets. As a 
result, millimetre uncertainties can result in significant target dose miss or OAR overdosage. 
Particle therapy facilities are nowadays equipped with similar in-room imaging capabilities as photon 
therapy facilities (Figure 7). For patient positioning, orthogonal kV imaging was available early-on 
(Figure 7a,b) and can potentially be used in fluoroscopy mode to track the movement of anatomical 
structures or markers as suggested for the real-time-image gated, spot-scanning proton beam therapy 
(RGPT) system at the Hokkaido University (Figure 7c)(Shimizu et al 2014, Umezawa et al 2015) or 
for carbon-ion scanning (Figure 7d)(Mori et al 2016). A specific x-ray imaging implementation is 
available at the Paul Scherer Institute (PSI), enabling BEV imaging (Figure 7e) (Pedroni 2006, Safai 
et al 2012). (Zhang et al 2013) describe a method by which 3D motion can be extracted from such a 
monoscopic, real-time imaging system. Optical surface imaging was introduced in proton therapy 
facilities over the last years (Batin et al 2016) and showed to be more robust in monitoring respiratory 
motion than electromagnetic monitoring in controlled laboratory conditions (Fattori et al 2017). 
Furthermore, efforts are made towards hybrid motion monitoring system (Cho et al 2017) using 
optical systems in combination with fluoroscopy systems. Optical imaging may have a more 
important role to play in monitoring patient motion during particle therapy and respiratory motion 
management than pre‐treatment patient positioning when compared to volumetric CBCT/in‐room CT 
image guidance methods (Fattori et al 2016, Ciocca et al 2016). Clinical application of ultrasound 
imaging in particle therapy has been rare, yet a phantom-based experiment has shown that real-time 
ultrasound motion detection and beam tracking enable considerably reduced interplay effects in 
scanned ion beam radiotherapy (Prall et al 2014). 
Also, more and more studies about online MR-guided proton therapy have been published in the 
recent years (Raaymakers et al 2008, Wolf and Bortfeld 2012, Moteabbed et al 2014, Hartman et al 
2015, Oborn et al 2015, Fuchs et al 2017, Schellhammer et al 2018), envisioning new ways to enable 
motion monitoring and mitigation. A recent review paper by (Oborn et al 2017) predicted the 
accelerated development of hardware and simple prototype systems within a few years and coupled 
systems integrated with gantries in a decade. For the time being, online MR-guided proton therapy 
however remains a pure research topic far away from clinical implementation. 
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Despite the availability of imaging equipment, the provided information is often not sufficient to 
employ the same motion monitoring and motion mitigation concepts as for photon therapy. Surrogate 
motion information (e.g. from an implanted marker) might not be sufficient in particle therapy to 
guarantee target dose coverage. This is due to the sensitivity of particles not only to geometrical 
changes but also density changes along the beam path. Thus, to accurately assess the influence of 
motion on particle dose distributions, 4D anatomical images of the whole patient geometry within the 
beam path are required. Currently, mainly static targets are treated at proton therapy facilities. If at all, 
moving targets are treated in breath-hold or with gating (Minohara et al 2000, Bert et al 2009, He et al 
2014, Zhang et al 2015, Yamada et al 2016). Tracking by steering the proton beam according to the 
target motion remains a research topic (Bert et al 2007, Grözinger et al 2008, Zhang et al 2014b). 
 
Figure 7: Imaging during particle therapy. Gantry mounted CBCT systems on (a) the Varian probeam (Image provided 
courtesy of Varian) or (b) the IBA system could be used in real-time fluoroscopy mode. Stereoscopic imaging was integrated 
with (c) proton beam scanning (reprinted from (Shimizu et al 2014) under CC BY licence.) and (d) carbon ion beam 
scanning (reprinted with permission from (Mori et al 2016)). (e) B x-ray imaging is available only at the PSI facility. The 
photo shows the x-ray tube mounted on the final bending magnet. (reprinted with permission from (Zhang et al 2013)). 
Implanted FM are associated with specific particle therapy-related challenges requiring particular 
precaution (Kubiak 2016). Although commercially available markers are popular in photon 
radiotherapy, the feasibility of their direct implementation in particle therapy is still under 
investigation. In the PROMETHEUS trial carried out at the Heidelberg Ion Beam Therapy (HIT) 
Center, different markers were evaluated for suitability for the treatment of hepatocellular carcinoma 
using scanned ion beams (Habermehl et al 2013). A concern for the use of FM in particle therapy is 
that they are made of high-Z materials causing unfavourable artefacts in conventional CT scans 
(Schlosser et al 2010). The inaccurate representation of the electron density and thus Hounsfield units 
near the inserted clips may result in improper dose calculation (Habermehl et al 2013). Furthermore, 
metal markers can interact with particle beams (particularly scanned ion beams) and have a 
considerable impact on the therapy (Bert and Durante 2011). The degree of their influence on the dose 
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distribution, fluence and range of ions depends on the material, thickness and location in the treatment 
field. Only thin markers (<0.5 mm) or those made of relatively low-Z materials, e.g. carbon-coated 
zirconium oxide clips, may be considered for use in particle therapy (Habermehl et al 2013). 
Electromagnetic localization of internal transponders is an alternative method of motion detection. At 
PSI the TULOC system was developed and successfully tested (Seiler et al 2000) although it has not 
been used clinically. An alternative implementation is the Calypso system described in section 2.4.1. 
(Balter et al 2005). In their review, (Landry and Hua 2018) point out that electromagnetic monitoring 
systems currently suffer from significant distortions which limit their use in a clinical particle therapy. 
Precise motion monitoring is the premise for adaptive 4D particle therapy. Most publications agree 
that the impact of motion in particle therapy (especially PBS) is highly individual for a specific set of 
patient characteristics and machine parameters as well as their specific combinations per treatment 
fraction. Thus, it is hard to predict dosimetric consequences of the tumour motion in prospective 
multiple scenarios evaluations. More and more publications underline the value of log file based dose 
reconstruction and accumulation to move towards 4D adaptive PBS particle therapy (Krieger et al 
2018, Klimpki et al 2018, Pfeiler et al 2018). For such approaches, high-frequency, low-latency, 
synchronized motion monitoring data is required. 4D-dose-accumulation treatment-assessment tools 
are in the phase of clinical implementation (Meijers et al 2019), allowing for a quality assessment of 
the 4D delivered dose throughout the treatment course triggering decisions for plan adaptations, in 
case of significant deviations. 
5. Conclusions and outlook 
This review compared and analysed the different real-time motion monitoring methods that have been 
clinically demonstrated. It illustrates the variety in hardware-focused methods (e.g. stereoscopic 
imaging, dedicated tracking machines, MR-linac) and software-focused methods on standard-
equipped linacs (e.g. KIM, sequential stereo, COSMIK, kV/MV monitoring). Add-on equipment 
represents a middle ground albeit also covering a spectrum between out-of-the-box systems (e.g. 
Calypso) and more processing-intensive or user-dependant methods (e.g. ultrasound). In all three 
categories, effort has been made to monitor soft tissues and tumours rather than internal or external 
surrogates with the MR-linac as a dedicated machine, US as an add-on imaging technology and 
markerless monitoring of lung tumours and bronchi on conventional linacs. However x-ray imaging is 
limited by its inherently poorer soft tissue contrast than MR or US imaging. The choice of equipment 
and method(s) to implement depends on three main factors. First: the treatment site. Respiratory 
surrogate and hybrid monitoring for example are not applicable for prostate where gastro-intestinal 
activity dominates organ motion. The strong reflection of ultrasound at tissue/air interfaces makes 
ultrasound imaging a contraindication for direct lung tumour monitoring. Markerless x-ray based 
monitoring is difficult in large patients as well as in the abdomen and pelvis due to poor contrast. 
Second: the motion mitigation strategy. A high monitoring frequency may not be necessary for gated 
prostate or spine treatments because of the slow motion. However, large excursion of the prostate due 
to gas movement may require monitoring with a higher frequency in extreme hypofractionated 
prostate RT. On the other hand, tracking tumours that move with respiration requires a high-frequency 
low-latency signal in combination with prediction algorithms. Hybrid monitoring is well suited for 
respiratory gating where kV imaging can be optimally used during MV beam-on time only. Latency 
of motion monitoring methods are generally calculated indirectly from the entire real-time adaptation 
system latency. The AAPM task group 76 report suggests that the total latency period of a real-time 
tracking system should be kept as low as possible and below 0.5 s for respiratory motion because of 
prediction algorithms limitations (Keall et al 2006). Given the slower motion of certain targets such as 
the prostate or the spine, imaging rates and monitoring latencies of a second or more may be 
acceptable for these targets. Similarly, baseline drift correction and tumour trailing for sites affected 
by respiratory motion may not require a latency as low as 0.5 s. The third factor is material and human 
resources. A specialized machine may be optimally used in large centres where a large volume of 
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patients justifies the investment and staff training. Smaller centres may prefer the versatility of 
standard-equipped linac methods or mobile add-on equipment. FM or electromagnetic 
transponder/transmitter implantation is also a complex procedure requiring specific 
radiologist/bronchoscopist training and a good coordination in scheduling between different services. 
This review also points out the variety of metrics used in reporting target motion amplitude and 
motion monitoring accuracy. Percentile ranges are useful to determine ITV margins. Population mean 
and SD of motion are often reported because they directly translate to random and systematic 
component of margin calculation (van Herk 2004) while the RMS, also known as quadratic mean, is 
less frequently reported. Yet, population-based measures do not adequately represent the variety in 
individual motion patterns. The amount of time the target spends at a certain distance from its planned 
position may also be useful to determine the margin robustness to motion. Different measures are 
therefore pertinent to different sites and applications and can be reported on a population or on a per-
patient basis. In order to facilitate the comparison of motion monitoring reports, we recommend to 
include population mean and SD for all directions of motion as well as the maximum mean and SD of 
motion observed in a single patient and fraction to illustrate outlying but nonetheless realistic cases.  
The accuracy of motion monitoring methods can be reported with similar measures as target motion. 
BEV errors are sometimes reported instead of errors in each directions of motion. BEV errors may be 
sufficient for photon therapy but inline errors should also be considered in particle therapy due to 
range uncertainty. As mentioned in the introduction of section 2, accuracy is often defined as the 
mean error which is not compliant with the ISO 5725-1 standard (ISO 1994). We recommend that 
motion monitoring methods are described by their accuracy as the combination of the trueness (error 
mean) and precision (standard deviation). 
Motion mitigation is an obvious application of motion monitoring and several mitigation methods 
have been compared in different treatment sites (Nankali et al 2018, Toftegaard et al 2017, Ehrbar et 
al 2016, 2017a, Colvill et al 2016, Menten et al 2012). Another application of motion monitoring is 
real-time dose reconstruction which can provide real-time QA for treatments delivered with or 
without mitigation (Ravkilde et al 2014, 2018, Kamerling et al 2016a, 2017). Motion monitoring and 
real-time dose reconstruction are the essential foundation of online replanning (Kontaxis et al 2017, 
Kamerling et al 2016b). Motion-including dose reconstruction can also help to develop dose-response 
models and evaluate clinical outcome based on the actually delivered dose instead of the planned dose 
(Bentzen et al 2010, Meijers et al 2019, Siochi et al 2015). 
IGRT – the integration of imaging and treatment in a single machine – revolutionized radiotherapy 
and has opened “many doors for exploration” (Jaffray 2012). The exploration of x-ray based imaging 
resulted in the clinical implementation of many methods discussed in this review and more 
developments are still ahead (see section 2.2 and 2.3). Even more doors are now open with a new 
form of IGRT: MR guidance. Progress in image processing and robotics may also facilitate wider 
implementation of US imaging. Particle therapy puts higher demands on motion monitoring than 
photon therapy. At modern proton facilities, almost the same imaging capabilities are nowadays 
available as in photon therapy. If they will be employed in the same way in clinical routine remains to 
be shown in the coming years.  
The methods presented in this review were developed and implemented over about 20 years with 
increasing level of surrogate quality and dimensionality. The state-of-the art has shifted from 
respiratory surrogate monitoring, to single and to multiple implanted marker monitoring and 
ultimately, imaging the tumour itself and/or the surrounding soft tissue with MR or US imaging. In 
the same fashion, 1D breathing signals and 2D imaging were replaced by 3D inferred or triangulated 
positions and 6 DoF monitoring while multiple object monitoring and motion models are aiming at 
monitoring the position of the target and the surrounding organs which may move differently than the 
target. This evolution shows that the community not only wants to “see what we treat as we treat” but 
wants to see it in ever more detail. There is also a growing interest in performing functional imaging 
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during treatment (Datta et al 2018, Fan et al 2012). Functional imaging or the monitoring of 
biological functions such as blood flow and cellular dynamics are not yet feasible in real-time in a 
radiation therapy setting, and as such were considered beyond the scope of this review. However, 
these effects likely play an important role in tumour control and toxicity effects of radiation therapy. 
As well as the introduction of imaging in the treatment room (IGRT) paved the way to real-time 
motion monitoring of tumour and OAR position, the introduction of functional imaging in the 
treatment room is likely to open the way to real-time biology-guided radiation therapy. 
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